3
Announcements
Trials
Browse
Landscape
Phase
Phase 1
1
Status
Completed
1
Sponsor Class
INDUSTRY
1
Study Type
Interventional
1
Sponsor
Cancer Type
Genitourinary
1
Conditions
Neoplasms
8
Neoplasm Metastasis
5
Colorectal Neoplasms
4
Carcinoma, Non-Small-Cell Lung
3
Advanced Solid Tumor
3
Stomach Neoplasms
2
Ovarian Neoplasms
2
Lung Neoplasms
2
Glioblastoma
2
Sarcoma
1
Pancreatic Neoplasms
1
Neoplasms, Plasma Cell
1
Liver Neoplasms
1
Leukemia
1
Kidney Neoplasms
1
Hypertension
1
Head and Neck Neoplasms
1
Gastrointestinal Stromal Tumors
1
Colonic Neoplasms
1
Choriocarcinoma
1
Cholangiocarcinoma
1
Carcinoma, Renal Cell
1
Carcinoma
1
Breast Neoplasms
1
Brain Neoplasms
1
Advanced Tumor
1
Advanced Solid Malignancies
1
Advanced Prostate Adenocarcinoma
1
Advanced Breast Cancer
1
Interventions
cediranib
1
Leuprolide
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
INDUSTRY
×
Advanced Prostate Adenocarcinoma
×
cediranib
×
Clear all
NCT00502164
2011-01-21
AZD2171IL/0003
AstraZeneca
Phase 1
Completed
40 enrolled